Services  /  Meibomian Gland Dysfunction
Condition

Understanding Meibomian Gland Dysfunction

The glands in your eyelids produce the oil layer that keeps your tears from evaporating. When they stop working, no amount of eye drops will fix the root problem. We find out exactly what’s happening — and treat it at the source.

86%
of dry eye patients
have MGD involvement
344M
people affected by
dry eye worldwide
more common in
women than men
75%
of cases go
undiagnosed
About this condition

What is Meibomian Gland Dysfunction?

Meibomian gland dysfunction — or MGD — is the single most common cause of dry eye disease. Your Meibomian glands line the edges of your upper and lower eyelids (roughly 30–40 in each upper lid, 20–30 in each lower). Their job is to produce meibum, the thin oil layer that sits on top of your tear film and prevents it from evaporating.

When these glands become blocked, inflamed, or damaged, the oil layer breaks down. Your tears evaporate too quickly — and the result is the burning, grittiness, and fluctuating vision that defines evaporative dry eye. Over time, glands that stay blocked can atrophy permanently, which is why early diagnosis matters.

MGD is remarkably common: research suggests it affects up to 86% of dry eye patients. Yet it’s frequently missed in routine eye exams because the glands aren’t visible without specialized imaging. Many patients are told their eyes “look fine” while their glands are quietly deteriorating.

Why early assessment matters

Unlike aqueous-deficient dry eye (where the problem is tear volume), MGD is a structural problem — the glands themselves aren’t functioning. Artificial tears provide temporary relief but don’t address the underlying cause. Effective treatment requires identifying the specific type and severity of gland dysfunction and targeting it directly.

There’s also a time factor that’s frequently overlooked. Meibomian glands that are blocked but still structurally intact can often be restored with the right treatment. Glands that have already fully atrophied — shrunk and dropped out — cannot regenerate. This is the reason we recommend assessment sooner rather than later: the glands we can still save are the ones worth acting on now.

Symptoms

Symptoms You May Recognise

MGD often develops gradually. You may have adapted to these symptoms without realising they point to a treatable condition:

  • Burning, stinging, or a gritty “sandpaper” sensation — especially later in the day
  • Eyes that water excessively, particularly in wind or air conditioning
  • Blurry vision that clears temporarily when you blink
  • Red, irritated eyelid margins — sometimes with visible crusting
  • Contact lenses that have become uncomfortable or intolerable
  • A feeling of heaviness or fatigue in your eyes
  • Sensitivity to light that wasn’t there before

If several of these sound familiar, MGD is a likely contributor. The encouraging news: once properly diagnosed, it responds well to targeted treatment.

Diagnosis

How We Diagnose MGD

A comprehensive dry eye assessment at UDEI goes well beyond a standard eye exam. We use specialised diagnostic technology to evaluate your Meibomian glands directly — not just your symptoms.

Symptom & History Review

We start by listening. Your experience matters — when symptoms started, what makes them worse, what you’ve already tried. This history shapes the rest of the assessment.

Meibography — Direct Gland Imaging

This is the single biggest difference between a standard dry eye workup and the assessment we do at UDEI. Using infrared meibography, we capture high-resolution images of the meibomian glands hidden inside your eyelids — structures that are completely invisible on a routine exam. The images show us the exact length, shape, and density of each gland, which ones are blocked but still viable, which have started to truncate, and which have already dropped out entirely.

We use these images to grade gland dropout, track changes over time, and tailor treatment to what your glands can realistically still recover. It’s also how we show you — in pictures, not just words — what’s happening beneath your lid margin and why a particular treatment plan makes sense for your specific pattern of gland loss.

Tear Film Analysis

We measure your tear osmolarity (salt concentration) and assess your lipid layer thickness. Elevated osmolarity and a thin lipid layer are hallmarks of evaporative dry eye caused by MGD.

Gland Expression Assessment

We gently evaluate the quality and flow of meibum from your glands. Healthy glands produce clear, olive-oil-consistency meibum. Dysfunctional glands produce thick, opaque, toothpaste-like secretions — or nothing at all.

Personalised Treatment Plan

Based on all findings, we map out a treatment strategy tailored to your specific type and severity of MGD. No two patients are the same — and neither are their treatment plans.

Treatment options

How We Treat MGD

MGD responds best to a layered approach — targeting the underlying gland dysfunction, not just masking symptoms. Your treatment plan will depend on the severity and type of gland involvement we identify during your assessment.

Treatment at UDEI is sequenced, not stacked. We typically start by clearing inflammation and bacterial load at the lid margin, then restore flow through the glands with thermal and light-based therapy, and finally lock in the gains with a home regimen you can actually maintain. Advanced interventions like gland probing are reserved for glands that need them — not offered as a default upgrade.

UltraView DEL™

Intense pulsed light therapy for patients with mild to moderate MGD seeking targeted in-clinic relief.

Mild to moderate MGD
Learn about UltraView DEL →

Meibomian Gland Expression

Targeted manual or instrument-assisted expression clears blocked glands and restores meibum flow. Often combined with thermal therapy for best results.

Moderate MGD

Meibomian Gland Probing

For severely scarred or fibrotic glands, specialised micro-probing opens obstructed ducts and clears years of accumulated debris. Reserved for cases unresponsive to other therapies.

Severe MGD

Lid Hygiene & ZoHx

Professional lid debridement removes bacterial biofilm and debris for patients where blepharitis coexists with MGD.

MGD + Blepharitis
Learn about ZoHx →

Prescription Drops

Anti-inflammatory and immunomodulatory drops address the underlying inflammation driving gland dysfunction. Often used alongside in-clinic treatments for comprehensive control.

Adjunct therapy

Home Care Protocol

Warm compresses, omega-3 supplementation, and lid hygiene form the maintenance foundation. We design a specific home regimen based on your gland health.

All severities

Most patients benefit from a combination of treatments rather than a single approach. We’ll guide you through the options and adjust as your glands respond.

Connected care

MGD and Your Broader Eye Health

MGD rarely exists in isolation. If you’re experiencing other eye conditions alongside dry eye, you have access to the full U Vision Group network:

Preparing for cataract surgery? Optimising your Meibomian glands before and after surgery improves both comfort and visual outcomes. Our team works closely with the surgeons at Uptown Eye Specialists to ensure your ocular surface is ready.

Considering laser vision correction? MGD is a common contributor to post-LASIK dryness. Pre-treatment at UDEI is part of the shared care protocol with U Eye Laser Cosmetic.

Need therapeutic eyewear or home care products? U Optical carries moisture-chamber eyewear and U Shoppe stocks clinician-selected dry eye products for ongoing maintenance.

Common questions

Frequently Asked Questions

Not exactly. “Dry eye” is an umbrella term that covers multiple causes. MGD is the most common type — responsible for the majority of dry eye cases — but there are other types, such as aqueous deficiency, where the problem is tear volume rather than tear quality. Your assessment at UDEI will identify which type (or combination) you have, so treatment targets the right mechanism.

MGD is a chronic condition, meaning it can be managed very effectively but typically requires ongoing attention. With the right combination of in-clinic treatments and home care, most patients experience significant, lasting improvement in comfort and tear stability. The key is catching it before irreversible gland loss occurs — and maintaining your results with a home care routine.

Several factors contribute: age (gland function naturally declines), hormonal changes (particularly in women during menopause), prolonged screen use (reduced blink rate lets glands stagnate), environmental factors (dry air, air conditioning), certain medications (antihistamines, antidepressants, isotretinoin), contact lens wear, and chronic eyelid inflammation (blepharitis). Most patients have multiple contributing factors.

Artificial tears can provide temporary symptom relief by supplementing your tear film, but they don’t address the underlying gland dysfunction. Prescription anti-inflammatory drops can help reduce the inflammation driving MGD, but they work best as part of a comprehensive plan that includes direct gland treatments like UltraView DEL or meibomian expression. Drops alone rarely resolve moderate-to-severe MGD.

Most patients notice initial improvement within the first two weeks of treatment. Full benefit typically develops over four to eight weeks as gland function recovers. Your follow-up visits allow us to track measurable progress through gland imaging and tear film analysis. Your UDEI clinician will explain the specific timeline based on your assessment findings.

Once a Meibomian gland has fully atrophied — shrunk, truncated, and dropped out — current evidence is that it does not regenerate. What’s reversible is the dysfunction in glands that are still structurally present: blocked ducts can be cleared, inflammation can be calmed, and meibum quality can be restored. This is why early assessment matters. The glands we can still see on meibography are the ones we can work with. Treating MGD earlier preserves more of the glands you have; waiting often means losing tissue we cannot get back.

Often yes, but the relationship between contact lenses and MGD runs both ways. Lenses can worsen gland dysfunction by disturbing the lipid layer and shortening tear break-up time, and MGD in turn makes lens wear uncomfortable. For mild to moderate MGD, most patients can continue wearing lenses once the underlying gland disease is treated — sometimes with a change in lens material, replacement schedule, or daily wear time. For more advanced MGD, we may recommend a lens holiday while glands recover, then reintroduce wear carefully. The goal is healthy glands first, comfortable lens wear second.

Meibography uses infrared imaging to look through the back of the eyelid at the Meibomian glands, which would otherwise be invisible. Healthy glands appear as long, parallel, finger-like structures running from the lid margin upward. On the images we can see which glands are full-length and functional, which have started to truncate or shorten, which look distorted or tortuous, and which areas of the lid have lost glands entirely — what we call gland dropout. We grade the dropout, compare it across visits, and use those images to explain exactly what we’re seeing and why a particular treatment plan makes sense for your glands specifically.

Home care is the foundation that makes in-clinic treatment stick. The core routine is a warm (not hot) compress for 10 minutes once or twice daily, followed by gentle lid massage toward the lash line to help express softened oils, and a dedicated lid hygiene wipe or foam to keep the lid margin clean. On top of that, we’ll often recommend a high-quality omega-3 supplement, conscious blinking exercises during screen work, and a humidifier in dry indoor environments. We build you a specific regimen during your visit — generic routines pulled from the internet are usually either too much or too little for the glands you actually have.

OHIP covers standard ophthalmic examination; advanced diagnostics and in-office procedures such as UltraView DEL and meibomian gland probing are specialised services not covered. Extended health insurance often covers some prescription drops and in-office treatments. UDEI provides itemised receipts.

Take the next step

Ready for answers?

A comprehensive dry eye assessment is the first step toward understanding what’s happening with your Meibomian glands — and what we can do about it. Est. 2006, UDEI has been helping patients find lasting relief from dry eye disease.